The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.00
Bid: 82.90
Ask: 83.20
Change: 0.20 (0.24%)
Spread: 0.30 (0.362%)
Open: 81.50
High: 83.20
Low: 81.20
Prev. Close: 82.80
CLI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

18 May 2023 07:00

RNS Number : 7922Z
CLS Holdings PLC
18 May 2023
 

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

CLS Holdings plc

LEI: 213800A357TKB2TD9U78

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Creative Value Investment Group Limited, trading as:

1. Creative Value Investment I Limited

2. Creative Value Investment II Limited

3. Creative Value Investment III Limited

4. Creative Value Investment IV Limited

5. Creative Value Investment V Limited

6. Creative Value Investment VII Limited

7. Creative Value Investment VIII Limited

City and country of registered office (if applicable)

St. Peter Port, Guernsey

4. Full name of shareholder(s) (if different from 3.) v

Name

Security Services Nominee Limited as nominee for Creative Value Investment VII Limited

City and country of registered office (if applicable)

London, UK

5. Date on which the threshold was crossed or reached vi:

16 May 2023

6. Date on which issuer notified (DD/MM/YYYY):

17 May 2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

52.064921

0.000000

52.064921

206,807,524

Position of previous notification (if

applicable)

51.460706

0.000000

51.460706

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Ordinary Shares

GB00BF044593

held by Creative

Value

Investment I

Limited

31,544,136

7.941408

Ordinary Shares

GB00BF044593

held by Creative

Value

Investment II

Limited

29,838,374

7.511973

Ordinary Shares

GB00BF044593

held by Creative

Value

Investment III

Limited

33,336,606

8.392672

Ordinary Shares

GB00BF044593

held by Creative

Value

Investment IV

Limited

24,375,000

6.136539

Ordinary Shares

GB00BF044593

held by Creative

Value

Investment V

Limited

23,285,019

5.862130

Ordinary Shares

GB00BF044593

held by Creative

Value

Investment VI

Limited

3,528,389

0.888291

Ordinary Shares

GB00BF044593

held by Creative

Value

Investment VII

Limited

24,375,000

2,400,000

6.136539

0.604213

Ordinary Shares

GB00BF044593

held by Creative

Value

Investment VIII

Limited

34,125,000

8.591155

SUBTOTAL 8. A

206,807,524

52.064921

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment Group

Limited

52.064921

52.064921%

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment I

Limited

7.941408

7.941408%

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment II

Limited

7.511973

7.511973%

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment III

Limited

8.392672

8.392672%

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment IV

Limited

6.136539

6.136539%

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment V

Limited

5.862130

5.862130%

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment VI

Limited

0.888291

0.888291%

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment VII

Limited

6.740752

6.740752%

The Trustees of the Sten

and Karin Mortstedt

Family & Charity Trust

Creative Value

Investment VIII

Limited

8.591155

8.591155%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

London, UK

Date of completion

17 May 2023

 

 

 

 

 

Notes

 

i Please note this form should be read jointly with the applicable Disclosure Guidance and Transparency Rules Chapter 5 (DTR5) available on the following link: https://www.handbook.fca.org.uk/handbook/DTR/5/?view=chapter

 

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.

 

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

 

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all parties to the agreement referred to in DTR5.2.1 (a) or (d) the holder of financial instruments referred to in DTR5.3.1.

 

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in DTR5.2.1 (b), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in DTR5.2.1 (c), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in DTR5.2.1 (d), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in DTR5.2.1 (e), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in DTR5.2.1 (g), the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

 

v Applicable in the cases provided for in DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to DTR5.2 unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).

 

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

 

vii The total number of voting rights held in the issuer shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

 

viii If the holding has fallen below the lowest applicable threshold, please note that it might not be necessary to disclose the extent of the holding, only that the new holding is below that threshold.

 

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (DTR 5.3.3.A).

 

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

 

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only in this way will the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain by numbering each chain accordingly. Please see the below example: 

Name of ultimate controlling person A (chain 1)

Name of controlled undertaking B

Name of controlled undertaking C

Name of ultimate controlling person A (chain 2)

Name of controlled undertaking B

Name of controlled undertaking D

Name of ultimate controlling person A (chain3)

Name of controlled undertaking E

Name of controlled undertaking F

 

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

 

xvi Example: Correction of a previous notification.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLGZGMKNNNGFZM
Date   Source Headline
25th Apr 20243:33 pmRNSResult of AGM
15th Apr 20247:00 amRNSCLS Announces the Sale of Westminster Tower
11th Apr 20244:34 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSCLS Investor Presentation: Investor Meet Company
22nd Mar 20245:31 pmRNSAnnual Financial Report
14th Mar 20244:12 pmRNSDirector/PDMR Shareholding
14th Mar 20244:12 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSAnnual Financial Report
28th Feb 202412:00 pmRNSNotice of Results
7th Feb 20245:37 pmRNSDirector/PDMR Shareholding
9th Jan 20245:27 pmRNSDirector/PDMR Shareholding
8th Dec 20235:40 pmRNSDirector/PDMR Shareholding
21st Nov 20234:57 pmRNSDirector/PDMR Shareholding
21st Nov 202311:13 amRNSDirector Declaration
15th Nov 20237:00 amRNSQ3 Trading Update
20th Oct 20235:20 pmRNSDirector/PDMR Shareholding
25th Sep 20239:16 amPRNDirector Declaration
25th Sep 20237:00 amRNSDirectorate Change
12th Sep 20235:33 pmRNSDirector/PDMR Shareholding
12th Sep 20234:17 pmRNSDirector/PDMR Shareholding
4th Sep 20234:41 pmRNSDirector/PDMR Shareholding
4th Sep 20234:38 pmRNSTR-1 Notification of Major Holdings
23rd Aug 20234:05 pmRNSDirector/PDMR Shareholding
18th Aug 20233:59 pmRNSDirector/PDMR Shareholding
18th Aug 20233:55 pmRNSNotification of Major Shareholdings
11th Aug 20234:50 pmRNSDirector/PDMR Shareholding
1st Aug 202311:17 amRNSNotice of Results
7th Jul 20235:28 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:20 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCLS announces 30-year lease in Essen, Germany
27th Jun 20237:00 amRNSCLS announces the sale of three properties
23rd Jun 20233:15 pmRNSDirector/PDMR Shareholding
15th Jun 20235:51 pmRNSDirector/PDMR Shareholding
15th Jun 20235:49 pmRNSNotification of Major Shareholding
15th Jun 20235:44 pmRNSDirector/PDMR Shareholding
8th Jun 20232:14 pmRNSDirector/PDMR Shareholding
5th Jun 20234:51 pmRNSDirector/PDMR Shareholding
30th May 20232:55 pmRNSDirector/PDMR Shareholding
30th May 20232:52 pmRNSHolding(s) in Company
26th May 20234:39 pmRNSTotal Voting Rights
18th May 20237:02 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSHolding(s) in Company
12th May 20234:40 pmRNSDirector/PDMR Shareholding
11th May 20235:15 pmRNSDirector/PDMR Shareholding
27th Apr 20234:32 pmRNSResult of AGM
17th Apr 20231:57 pmRNSDirector/PDMR Shareholding
13th Apr 20233:51 pmRNSDirector/PDMR Shareholding
24th Mar 20237:22 amRNSNotice of Results
24th Mar 20237:17 amRNSDirector/PDMR Shareholding
15th Mar 20234:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.